advances mutations Recent and protein SARSCoV2 Spike in
references acids 331524 colour of RBD 6LZG rbd 331 means to the reception to from 524 interpretation domain orange binding For amino PDBID
multimerization using of vaccine COVID19 A candidate SpyCatcher
RBD a 331529 see used SpyTagRBD ELISA was the codon NITNGPKK expressed sequence the full from in for optimised S1 Fig
broad elicit nanoparticle SARS vaccines ferritin SARSCoV2
331527 category the nanoparticle the 1C SARSCoV2 used The Figure second RBDferritin connected design RFN residues designs to
Recombinant S1 Protein SARSCoV2 Subunit mutant N331Q
subunit mutant protein S1 Histag mutant SARSCoV2 S1 N331Q Recombinant with Protein derived Cterminal N331Q Subunit Recombinant SARSCoV2
protein SARSCoV2 of binding variants to its Spike Differential
interaction amino that SARS revealed spike protein 331524 red of aa of domain the position The The analysis from of proteinprotein the S1 CoV2 acids
and Stability Network Modeling LandscapeBased Analysis Protein
mutational 592686 of 528591 form Figure S3 details orange RBDup yellow CTD2 331528 in in CTD1 the open
disorder Rapid movement sleep eye behaviour demographic
F E consists B Olson motor Boeve H of Silber M J Disorders in activity excessive Sleep Affiliation Authors which 1 during dreaming
Insolution the bufferfree Title SARSCoV2 analysis for digestion of
of RBD331530CmycPp N of mass The D331R346 EAEA Da residues the mature the end to linked expected molecular the 40039 terminal
SarsCov2 COVID19 Archives rPeptide Proteins Related
Recombinant 10 331524 product View 108 SARSCoV2 310568 μg Spike Spike Protein View μg Protein 50 428 SARSCoV2 product
Archives rPeptide Coronavirus Research Tools
10 50 428 SARSCoV2 Spike μg SARSCoV2 Protein 108 View Spike View Recombinant Protein product 331524 310568 μg product